Navigation Links
Lipid peroxides -- more sophisticated than their reputation
Date:8/24/2010

This release is available in German.

In a joint study conducted by Helmholtz Zentrum Mnchen, the German Center for Neurodegenerative Diseases (DZNE) and a research group at Karolinska Institutet in Stockholm, Sweden, researchers have now discovered that lipid peroxides* play a specific physiological role in the cell. Prior to this study, scientists had already established that accumulation of lipid peroxides* indicate cell stress. Lipid peroxides have further been shown to be very potent inducers of cell death. The results of this study now demonstrate that chemically modified (oxidized) lipids temporarily inactivate protein tyrosine phosphatases*. These in turn regulate the cellular communication of receptor tyrosine kinases (RTK)*. This finding is of central importance because aberrant activation of the receptor tyrosine kinases contributes to many diseases, including cancer. Until now, only hydrogen peroxide was known to oxidize and inactivate protein tyrosine phosphatases and thus to have a regulating effect on kinases.

"We were able to show that lipid peroxides are 100-1000 times more effective than hydrogen peroxide," said Dr. Marcus Conrad, lead authors of the publication, who has since moved from Helmholtz Zentrum Mnchen to the German Center for Neurodegenerative Disease. Dr. Arne stman and sa Sandin from the Karolinska Institutet added: "It will be very interesting to see if lipid peroxides contribute to the activation of tyrosine kinases in cancer and other diseases, e.g. diabetes and Alzheimer's disease."

*Background

Lipid peroxides are chemically modified lipids or fatty acids, which, among other things, indicate cellular stress. In high concentrations they can trigger cell death. Elevated concentrations of lipid peroxides are often found in patients with common diseases such as atherosclerosis, diabetes, cancer or neurodegenerative diseases including Parkinson's and Alzheimer's disease.

Receptor tyrosine kinases (RTK) and protein tyrosine phosphatases have an important function in the regulation of cell growth and division. Over-active receptor tyrosine kinases play a key role in the etiology of cancer. A frequent cause of breast cancer, for instance, is a malfunction of the receptor tyrosine kinase HER-2 (human epidermal growth factor receptor 2). In healthy tissues and cells receptor tyrosine kinases are precisely regulated by protein tyrosine phosphatases.


'/>"/>

Contact: Sven Winkler
presse@helmholtz-muenchen.de
49-089-318-73946
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health
Source:Eurekalert

Related biology news :

1. The genetic heart of the lipids
2. Lipid droplets lead a Spartin existence
3. Boston University School of Medicine researcher awarded the 2010 Avanti Award in Lipids
4. Research reveals lipids unexpected role in triggering death of brain cells
5. Genetic causes identified for disturbances in lipid metabolism
6. University of Texas Southwestern Medical Center researcher wins Avanti Award in lipids
7. CHEO RI study uses sophisticated genetic engineering to improve insulin-producing beta cells
8. Women do not recover their muscle strength as fast as men
9. Beetles get by with a little help from their friends
10. Migratory moths may hitch their rides, but theyre anything but drifters
11. IOF calls on European citizens to stand tall and speak out for their bones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... 22, 2017  PrimeVax Immuno-Oncology, Inc. announced today its ... the Annual Biocom Global Life Science Partnering Conference.  The ... AM, at the Torrey Pines Lodge, in San Diego.  ... at Biocom who have chosen our company, amongst numerous ... companies, investors, and clinical researchers," said Mr. Chen. "In ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... and development of precision treatments for neurodegenerative diseases, today announced it has issued ... ProMIS approach.” This is one of a series of commentaries from ProMIS’s scientific ...
(Date:2/22/2017)... , Feb 22, 2017 Dublin ... the "Global Biological Crop Protection (Bio-Pesticide) Market-By Type, By Application, ... report to their offering. ... Global Biological Crop Protection Market is forecasted to ... The strong growth in biopesticide or biological crop protection market is ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... Spyker, PhD, MD former Acting Deputy Director in the FDA CDRH Division of ... Staff has joined the company as an Expert Consultant. , In Dr. Spyker’s ...
Breaking Biology Technology: